Form 4 for ELAN Elanco Animal Health Inc
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0001415889-25-005164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-19 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | A - Grant | $0.00 | +449.4K | 1.81M | +33% | $0 | |
| 2025-02-21 | 2025-02-19 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | F - Tax | $11.24 | -195.8K | 1.61M | -11% | -$2.20M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | A | A | 449,408 | $0.00 | 1,808,688 | D | — | — | (F2) Includes 1,751 shares acquired on January 31, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan. (F1) Corrects the number of shares purchased under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on December 30, 2022, June 30, 2023 and April 30, 2024 by deducting 825 shares. |
| 2 | Common | Common Stock | 2025-02-19 | F | D | 195,840 | $11.24 | 1,612,848 | D | — | — |